
07/08/2025
We’re proud to announce that the FDA has accepted our New Drug Application for ET-600, marking an important step forward in our commitment to advancing rare disease treatments.
At Eton, we are driven by our mission to bring innovative, meaningful therapies to patients who need them most. This milestone brings us closer to delivering a new treatment option for a rare condition with limited options.
🔗 Read the full press release here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-fda-acceptance-new-drug-1